Therapeutic Options for Sleep-Maintenance and Sleep-Onset Insomnia
Insomnia, defined as difficulty falling asleep, staying asleep, and/or experiencing restorative sleep with associated impairment or significant distress, is a common condition resulting in significant clinical and economic consequences. Many options are available to treat insomnia, to assist with ei...
Gespeichert in:
Veröffentlicht in: | Pharmacotherapy 2007-01, Vol.27 (1), p.89-110 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 110 |
---|---|
container_issue | 1 |
container_start_page | 89 |
container_title | Pharmacotherapy |
container_volume | 27 |
creator | Morin, Anna K. Jarvis, Courtney I. Lynch, Ann M. |
description | Insomnia, defined as difficulty falling asleep, staying asleep, and/or experiencing restorative sleep with associated impairment or significant distress, is a common condition resulting in significant clinical and economic consequences. Many options are available to treat insomnia, to assist with either falling asleep (sleep onset) or maintaining sleep. We searched MEDLINE for articles published between January 1996 and January 2006, evaluated s from recent professional meetings, and contacted the manufacturer of the most recent addition to the pharmacologic armamentarium for insomnia treatment (ramelteon) to gather information. Nonpharmacologic options include stimulus control, sleep hygiene education, sleep restriction, paradoxical intention, relaxation therapy, biofeedback, and cognitive behavioral therapy. Prescription and over‐the‐counter drug therapies include benzodiazepine and nonbenzodiazepine sedative‐hypnotic agents; ramelteon, a melatonin receptor agonist; trazodone; and sedating antihistamines. Herbal and alternative preparations include melatonin and valerian. Before recommending any treatment, clinicians should consider patient‐specific criteria such as age, medical history, and other drug use, as well as the underlying cause of the sleep disturbance. All pharmacotherapy should be used with appropriate caution, at minimum effective doses, and for minimum duration of time. |
doi_str_mv | 10.1592/phco.27.1.89 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68377474</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68377474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4241-2f6d37c25ad62d4300dc485a76baf769932309255e0dc8979d5a28efb87c94523</originalsourceid><addsrcrecordid>eNp90M1PwyAYBnBiNDo_bp5NL3qyEygUOKpRZ5zOz5h4IYy-jWhHK3RR_3u7rNGbJwj8nvdNHoR2CR4SruhR82rrIRVDMpRqBQ2IFDxVhLBVNMBUiBRjLDfQZoxvGFOSM7qONogganEfoJPHVwimgXnrbDJpWlf7mJR1SB4qgCa9Ns634I23kBhf9K8TH6FNLn2sZ96ZbbRWmirCTn9uoafzs8fTUTqeXFyeHo9TyygjKS3zIhOWclPktGAZxoVlkhuRT00pcqUymmFFOYfuQyqhCm6ohHIqhVWM02wLHSznNqH-mENs9cxFC1VlPNTzqHOZCcEE6-DhEtpQxxig1E1wMxO-NcF60ZledKap0ERL1fG9fu58OoPiD_cldWC_ByZaU5Whq8PFPycZwywnnSNL9-kq-P53qb4dHd9Tvsiky4yLLXz9Zkx417nIBNfPNxd6dH5FX8Z3TI-yH8Odkpw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68377474</pqid></control><display><type>article</type><title>Therapeutic Options for Sleep-Maintenance and Sleep-Onset Insomnia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Morin, Anna K. ; Jarvis, Courtney I. ; Lynch, Ann M.</creator><creatorcontrib>Morin, Anna K. ; Jarvis, Courtney I. ; Lynch, Ann M.</creatorcontrib><description>Insomnia, defined as difficulty falling asleep, staying asleep, and/or experiencing restorative sleep with associated impairment or significant distress, is a common condition resulting in significant clinical and economic consequences. Many options are available to treat insomnia, to assist with either falling asleep (sleep onset) or maintaining sleep. We searched MEDLINE for articles published between January 1996 and January 2006, evaluated s from recent professional meetings, and contacted the manufacturer of the most recent addition to the pharmacologic armamentarium for insomnia treatment (ramelteon) to gather information. Nonpharmacologic options include stimulus control, sleep hygiene education, sleep restriction, paradoxical intention, relaxation therapy, biofeedback, and cognitive behavioral therapy. Prescription and over‐the‐counter drug therapies include benzodiazepine and nonbenzodiazepine sedative‐hypnotic agents; ramelteon, a melatonin receptor agonist; trazodone; and sedating antihistamines. Herbal and alternative preparations include melatonin and valerian. Before recommending any treatment, clinicians should consider patient‐specific criteria such as age, medical history, and other drug use, as well as the underlying cause of the sleep disturbance. All pharmacotherapy should be used with appropriate caution, at minimum effective doses, and for minimum duration of time.</description><identifier>ISSN: 0277-0008</identifier><identifier>EISSN: 1875-9114</identifier><identifier>DOI: 10.1592/phco.27.1.89</identifier><identifier>PMID: 17192164</identifier><identifier>CODEN: PHPYDQ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Antidepressive Agents, Second-Generation - therapeutic use ; antihistamines ; benzodiazepines ; Biological and medical sciences ; Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes ; herbal products ; Histamine H1 Antagonists - therapeutic use ; Humans ; Hypnotics and Sedatives - therapeutic use ; insomnia ; Medical sciences ; melatonin ; Nervous system (semeiology, syndromes) ; Neurology ; nonbenzodiazepines ; nonpharmacologic therapies ; Nonprescription Drugs ; Phytotherapy ; ramelteon ; Receptors, Melatonin - agonists ; Sleep Initiation and Maintenance Disorders - therapy ; trazodone ; Trazodone - therapeutic use</subject><ispartof>Pharmacotherapy, 2007-01, Vol.27 (1), p.89-110</ispartof><rights>2007 Pharmacotherapy Publications Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4241-2f6d37c25ad62d4300dc485a76baf769932309255e0dc8979d5a28efb87c94523</citedby><cites>FETCH-LOGICAL-c4241-2f6d37c25ad62d4300dc485a76baf769932309255e0dc8979d5a28efb87c94523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1592%2Fphco.27.1.89$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1592%2Fphco.27.1.89$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4010,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18440461$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17192164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morin, Anna K.</creatorcontrib><creatorcontrib>Jarvis, Courtney I.</creatorcontrib><creatorcontrib>Lynch, Ann M.</creatorcontrib><title>Therapeutic Options for Sleep-Maintenance and Sleep-Onset Insomnia</title><title>Pharmacotherapy</title><addtitle>Pharmacotherapy</addtitle><description>Insomnia, defined as difficulty falling asleep, staying asleep, and/or experiencing restorative sleep with associated impairment or significant distress, is a common condition resulting in significant clinical and economic consequences. Many options are available to treat insomnia, to assist with either falling asleep (sleep onset) or maintaining sleep. We searched MEDLINE for articles published between January 1996 and January 2006, evaluated s from recent professional meetings, and contacted the manufacturer of the most recent addition to the pharmacologic armamentarium for insomnia treatment (ramelteon) to gather information. Nonpharmacologic options include stimulus control, sleep hygiene education, sleep restriction, paradoxical intention, relaxation therapy, biofeedback, and cognitive behavioral therapy. Prescription and over‐the‐counter drug therapies include benzodiazepine and nonbenzodiazepine sedative‐hypnotic agents; ramelteon, a melatonin receptor agonist; trazodone; and sedating antihistamines. Herbal and alternative preparations include melatonin and valerian. Before recommending any treatment, clinicians should consider patient‐specific criteria such as age, medical history, and other drug use, as well as the underlying cause of the sleep disturbance. All pharmacotherapy should be used with appropriate caution, at minimum effective doses, and for minimum duration of time.</description><subject>Antidepressive Agents, Second-Generation - therapeutic use</subject><subject>antihistamines</subject><subject>benzodiazepines</subject><subject>Biological and medical sciences</subject><subject>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</subject><subject>herbal products</subject><subject>Histamine H1 Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Hypnotics and Sedatives - therapeutic use</subject><subject>insomnia</subject><subject>Medical sciences</subject><subject>melatonin</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>nonbenzodiazepines</subject><subject>nonpharmacologic therapies</subject><subject>Nonprescription Drugs</subject><subject>Phytotherapy</subject><subject>ramelteon</subject><subject>Receptors, Melatonin - agonists</subject><subject>Sleep Initiation and Maintenance Disorders - therapy</subject><subject>trazodone</subject><subject>Trazodone - therapeutic use</subject><issn>0277-0008</issn><issn>1875-9114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90M1PwyAYBnBiNDo_bp5NL3qyEygUOKpRZ5zOz5h4IYy-jWhHK3RR_3u7rNGbJwj8nvdNHoR2CR4SruhR82rrIRVDMpRqBQ2IFDxVhLBVNMBUiBRjLDfQZoxvGFOSM7qONogganEfoJPHVwimgXnrbDJpWlf7mJR1SB4qgCa9Ns634I23kBhf9K8TH6FNLn2sZ96ZbbRWmirCTn9uoafzs8fTUTqeXFyeHo9TyygjKS3zIhOWclPktGAZxoVlkhuRT00pcqUymmFFOYfuQyqhCm6ohHIqhVWM02wLHSznNqH-mENs9cxFC1VlPNTzqHOZCcEE6-DhEtpQxxig1E1wMxO-NcF60ZledKap0ERL1fG9fu58OoPiD_cldWC_ByZaU5Whq8PFPycZwywnnSNL9-kq-P53qb4dHd9Tvsiky4yLLXz9Zkx417nIBNfPNxd6dH5FX8Z3TI-yH8Odkpw</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Morin, Anna K.</creator><creator>Jarvis, Courtney I.</creator><creator>Lynch, Ann M.</creator><general>Blackwell Publishing Ltd</general><general>Pharmacotherapy</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200701</creationdate><title>Therapeutic Options for Sleep-Maintenance and Sleep-Onset Insomnia</title><author>Morin, Anna K. ; Jarvis, Courtney I. ; Lynch, Ann M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4241-2f6d37c25ad62d4300dc485a76baf769932309255e0dc8979d5a28efb87c94523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antidepressive Agents, Second-Generation - therapeutic use</topic><topic>antihistamines</topic><topic>benzodiazepines</topic><topic>Biological and medical sciences</topic><topic>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</topic><topic>herbal products</topic><topic>Histamine H1 Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Hypnotics and Sedatives - therapeutic use</topic><topic>insomnia</topic><topic>Medical sciences</topic><topic>melatonin</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>nonbenzodiazepines</topic><topic>nonpharmacologic therapies</topic><topic>Nonprescription Drugs</topic><topic>Phytotherapy</topic><topic>ramelteon</topic><topic>Receptors, Melatonin - agonists</topic><topic>Sleep Initiation and Maintenance Disorders - therapy</topic><topic>trazodone</topic><topic>Trazodone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morin, Anna K.</creatorcontrib><creatorcontrib>Jarvis, Courtney I.</creatorcontrib><creatorcontrib>Lynch, Ann M.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morin, Anna K.</au><au>Jarvis, Courtney I.</au><au>Lynch, Ann M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Options for Sleep-Maintenance and Sleep-Onset Insomnia</atitle><jtitle>Pharmacotherapy</jtitle><addtitle>Pharmacotherapy</addtitle><date>2007-01</date><risdate>2007</risdate><volume>27</volume><issue>1</issue><spage>89</spage><epage>110</epage><pages>89-110</pages><issn>0277-0008</issn><eissn>1875-9114</eissn><coden>PHPYDQ</coden><abstract>Insomnia, defined as difficulty falling asleep, staying asleep, and/or experiencing restorative sleep with associated impairment or significant distress, is a common condition resulting in significant clinical and economic consequences. Many options are available to treat insomnia, to assist with either falling asleep (sleep onset) or maintaining sleep. We searched MEDLINE for articles published between January 1996 and January 2006, evaluated s from recent professional meetings, and contacted the manufacturer of the most recent addition to the pharmacologic armamentarium for insomnia treatment (ramelteon) to gather information. Nonpharmacologic options include stimulus control, sleep hygiene education, sleep restriction, paradoxical intention, relaxation therapy, biofeedback, and cognitive behavioral therapy. Prescription and over‐the‐counter drug therapies include benzodiazepine and nonbenzodiazepine sedative‐hypnotic agents; ramelteon, a melatonin receptor agonist; trazodone; and sedating antihistamines. Herbal and alternative preparations include melatonin and valerian. Before recommending any treatment, clinicians should consider patient‐specific criteria such as age, medical history, and other drug use, as well as the underlying cause of the sleep disturbance. All pharmacotherapy should be used with appropriate caution, at minimum effective doses, and for minimum duration of time.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17192164</pmid><doi>10.1592/phco.27.1.89</doi><tpages>22</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0277-0008 |
ispartof | Pharmacotherapy, 2007-01, Vol.27 (1), p.89-110 |
issn | 0277-0008 1875-9114 |
language | eng |
recordid | cdi_proquest_miscellaneous_68377474 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Antidepressive Agents, Second-Generation - therapeutic use antihistamines benzodiazepines Biological and medical sciences Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes herbal products Histamine H1 Antagonists - therapeutic use Humans Hypnotics and Sedatives - therapeutic use insomnia Medical sciences melatonin Nervous system (semeiology, syndromes) Neurology nonbenzodiazepines nonpharmacologic therapies Nonprescription Drugs Phytotherapy ramelteon Receptors, Melatonin - agonists Sleep Initiation and Maintenance Disorders - therapy trazodone Trazodone - therapeutic use |
title | Therapeutic Options for Sleep-Maintenance and Sleep-Onset Insomnia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A38%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Options%20for%20Sleep-Maintenance%20and%20Sleep-Onset%20Insomnia&rft.jtitle=Pharmacotherapy&rft.au=Morin,%20Anna%20K.&rft.date=2007-01&rft.volume=27&rft.issue=1&rft.spage=89&rft.epage=110&rft.pages=89-110&rft.issn=0277-0008&rft.eissn=1875-9114&rft.coden=PHPYDQ&rft_id=info:doi/10.1592/phco.27.1.89&rft_dat=%3Cproquest_cross%3E68377474%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68377474&rft_id=info:pmid/17192164&rfr_iscdi=true |